« | Home | »

Testosterone Therapy does not Increase the Risk of Prostate Cancer

By jeremyc | May 9, 2016

According to a recent study, men undergoing testosterone replacement therapy (TRP for short) do not have an increased risk of prostate cancer. If anything, the risk of prostate cancer in these men was found to be 50 percent lower than in men who had not been prescribed TRT.

This study was done by New York University researchers, who studied data for over two hundred thousand males living in Sweden. The primary aim of the study was to provide a definite answer to the question: Is there a link between TRT use and an increased risk of prostate cancer?

In the last decade, there has been a sharp rise in TRT use, even when the long-term risks associated with have not been established. Although a pooled analysis done recently pointed that men prescribed TRT didn’t have any increased risk of prostate cancer, it had many limitations. For one, the studied sample size was small. Two, long-term TRT use was not looked at. Three, there was no control group.

On the other hand, in this study researchers looked at a large sample data. According to them, men who had been using TRT for over a year had a 50 percent lower chance of developing prostate cancer than those who are not using TRT. How TRT is delivered (that is, by patch, mouth, or injection) does not affect a person’s risk of prostate cancer at all.

Topics: | Prostate | No Comments »

Comments are closed.